gaboxadol has been researched along with Psychotic Disorders in 1 studies
gaboxadol: GABA agonist; inhibitor of GABA uptake systems; structure
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rudissaar, R | 1 |
| Pruus, K | 1 |
| Skrebuhhova-Malmros, T | 1 |
| Allikmets, L | 1 |
| Matto, V | 1 |
1 other study available for gaboxadol and Psychotic Disorders
| Article | Year |
|---|---|
Involvement of GABAergic neurotransmission in the neurobiology of the apomorphine-induced aggressive behavior paradigm, a model of psychotic behavior in rats.
Topics: Aggression; Animals; Apomorphine; Baclofen; Behavior, Animal; Disease Models, Animal; GABA Agonists; | 2000 |